Advanced Insulin Management Program Reduces A1C Levels and Regimen-Related Distress Without Weight Gain in Patients With Type 1 Diabetes Mellitus

Lisa H. Fish, MD, Harry P. Wetzler, MD, Janet L. Davidson, RN, Cori L. Ofstead, MSPH, and Mary L. Johnson, RN

The Epidemiology of Diabetes Interventions and Complications Study showed the importance of early, intensive insulin treatment in patients with type 1 DM. Intensive treatment using MDIs or CSII is one aspect of attaining enhanced control. Current evidence also indicates that education and guidance from a diabetes care team are useful in improving control. The International Diabetes Center has developed an innovative, outcomes-driven, Advanced Insulin Management (AIM) program to assist patients in achieving better control.